Agenda
- Recent CGT market dynamics overview and the outlook
- Best practices for managing the special CGT supply chain and product delivery
- New reimbursement models on a global basis
Speaker：Amit Agarwal, Managing Director, Deloitte Consulting
Amit Agarwal
Managing Director
Life Sciences
San Francisco, CA
Amit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations Amit co-leads the Next Generation Therapies practice. The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space. Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects.
Amit also has experience as Vice President at Leerink Swann & Co., a boutique investment bank focused on the life sciences. He helped innovative life science companies raise capital, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker.
Amit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine. Amit has presented at multiple conferences in North America, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms.
Amit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and pre-med from Occidental College. Prior to business school, Amit conducted research in neurobiology at the California Institute of Technology and was an American diplomat posted in China and the Middle East.
This webinar is sponsored by Deloitte. The Deloitte Chinese Services Group (CSG) provides professional support for life sciences and healthcare companies engaged in cross-border investments and business between Greater China region and the United States. https://bit.ly/2IX5MDf